Chapter 13: Drug Therapy in Older Adults

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we talk about a medical diagnosis or even just administering a medication, there's this expectation of precision.

Right, like it's a math problem.

Exactly.

It's almost like engineering.

You have a patient with a headache, you give an analgesic, the headache goes away, the cause and effect are clean.

It's comforting because, I mean, we naturally want clinical practice to be predictable.

Yeah, the very binary way of looking at medicine.

You know, problem, then solution,

broken, then fixed.

But then you step into the world of geriatric nursing and suddenly that clean, predictable machine just, it doesn't work the same way.

We're looking at a pharmacological landscape that is incredibly murky.

Oh, absolutely.

You give the same dose of the same drug to an 85 -year -old that you just gave to a 45 -year -old and you get a completely different, sometimes catastrophic result.

It is the absolute definition of clinical muddy waters and navigating those waters requires a complete shift in how you think about human biology.

Welcome to a special deep dive.

If you are listening to this right now, chances are you are a nursing student, maybe prepping for a massive pharmacology exam or getting ready to step onto the floor for your clinicals.

We see you.

We definitely see you.

Today, we are taking your source material, specifically the principles from Lane's Pharmacology for Nursing Care Focusing on Drug Therapy in Older Adults.

And we are going to decode it.

We are translating the dense pharmacology into plain language with tight cause and effect reasoning.

Because memorizing a list of drugs to avoid is one thing, but understanding the underlying mechanisms like the actual why and how the body is failing, that is what keeps your patients safe.

And let's ground this with a staggering foundational fact from the text.

Older adults, so those 65 and older, make up only about 12 .8 % of the U .S.

population, but they consume 33 % of the nation's prescribed drugs.

That statistic perfectly frames the challenge.

You are dealing with a population experiencing increased severity of illness, multiple overlapping pathologies, and quite frankly, excessive prescribing.

But before we even touch a specific medication,

the core philosophy of care has to fundamentally shift.

Older adults typically suffer from chronic progressive illnesses.

So the primary goal of nursing care moves away from curing the patient.

Because a cure is often biologically impossible at that stage.

Exactly.

The objective becomes reducing symptoms and improving the quality of life.

And to do that safely, you have to trace the pharmacokinetics.

Following the drug's actual physical journey through the aging body, right?

Starting the second the pill is swallowed.

Okay, let's unpack this.

Let's start there with absorption.

The natural assumption is that because an older adult's digestive tract is aging, they absorb less of the drug.

Yeah, that makes intuitive sense.

It does.

But the key takeaway from the clinical data is that altered gastrointestinal absorption is actually not a major factor in drug sensitivity for older adults.

Wait, really?

Yeah, the overall percentage or the total amount of an oral dose that eventually gets absorbed doesn't really change with age.

Oh, okay.

So it's not that the drug isn't getting into the systemic circulation.

It's just taking its sweet time getting there.

The rate is delayed.

Right.

The speed limit drops.

The biological mechanism behind that delay is reduced splanchnic blood flow.

That's the blood flow to the abdominal organs combined with delayed gastric emptying.

The gastrointestinal motility just slows down.

Exactly.

On top of that, gastric acidity is reduced in older adults.

Which fundamentally changes the math for certain drug formulations that require a highly acidic stomach environment to dissolve properly.

Without that high acid, the pill just sits there longer before it can be broken down and absorbed.

Moving along the pharmacokinetic pathway, once the drug is finally absorbed, we look at distribution.

Like, where does the drug actually go and where does it hide in the body?

I was trying to visualize the shifting body composition of an older adult, and the best analogy I could come up with based on the text is a changing landscape of sponges and shot glasses.

Oh, I like that visual.

Let's break down the physiology behind it.

First, as human beings age, our percentage of body fat naturally increases.

That's the sponge.

Right.

That extra body fat acts as a massive storage depot for lipid -soluble drugs.

Take a beta blocker like propranolol, for example.

Yes, it's highly lipid -soluble.

Exactly.

It gets soaked up and stored in that extra adipose tissue.

Consequently, the plasma levels of the drug, the amount actually circulating in the bloodstream, are significantly reduced.

Less active drug in the blood means you get a reduced clinical response.

Yes.

But then we have the exact opposite problem playing out at the same time.

Lean body mass and total body water decrease as we age.

And that is your shot glass.

Yeah, that's the shot glass.

Because there is less total water in the aging body, water -soluble drugs like ethanol have a much smaller volume to distribute into.

You are essentially pouring the same amount of a highly active substance into a much smaller container.

Which means the concentration of the drugs spikes dramatically.

The effects become much more intense, even at what we would consider a normal dose.

Wow.

Sponges soaking up lipid -soluble drugs, shot glasses concentrating water -soluble drugs.

But there's one more critical distribution factor in the plasma itself,

right?

Serum albumin.

This is a major one for clinical practice.

In healthy older adults, albumin is only slightly reduced.

But in older adults who are malnourished or suffering from a chronic illness,

albumin levels drop significantly.

And albumin is a transport protein, right?

Many drugs bind to it to travel safely through the bloodstream.

Precisely.

If the drug is bound to the protein, it's inactive.

It can't cross into the tissue to exert an effect.

So if a patient has decreased protein binding sites because their albumin is severely low, the drug molecules have nowhere to park.

You end up with a massive surge of free, unbound, active drug floating around in the systemic circulation.

And the clinical effects can escalate into toxicity very quickly.

Very quickly.

So the drug has been absorbed slowly, it's been distributed erratically, but eventually the body has to break it down to remove it.

Which brings us to metabolism and excretion.

And according to the clinical data, this is where the most dangerous pitfalls happen for nurses.

What is physically happening to the aging liver?

Well, rates of hepatic drug metabolism consistently decline with age.

The liver is simply not processing chemicals at the speed it used to.

Biologically, this is due to reduced hepatic blood flow, shrinking liver mass, and a measurable decrease in the activity of specific hepatic enzymes.

So the liver is sluggish.

For drugs that rely on the liver for clearance, their half -lives increase.

They stick around longer, prolonging their therapeutic or toxic responses.

But it's a fascinating and highly dangerous nuance here regarding oral medications.

Many oral drugs normally undergo extensive first -pass metabolism.

In a younger patient, the liver acts as a heavy filter,

processing and inactivating a large portion of that oral drug before it ever reaches the systemic circulation.

But if that older liver is losing its filtering power… …then significantly fewer drug molecules are inactivated during that first pass.

A much larger percentage of the active drug makes it pass the liver and into the bloodstream.

Oh, wow.

So you might give a standard oral dose, but the clinical response is massively enhanced because the liver didn't do its usual gatekeeping.

Exactly.

That is a critical mechanism to keep in mind.

Okay, so metabolism is impaired, but then we hit excretion.

And the pharmacology texts are incredibly explicit here.

Declining kidney function is the single most important pause of adverse drug reactions, or ADRs, in older adults.

Without a doubt.

But I want to push back on this from a practical nursing standpoint.

I'm looking at my older patient's chart.

I check their daily metabolic panel.

Their serum creatinine levels are sitting squarely in the normal range.

Right.

How am I supposed to catch a life -threatening kidney decline if the lab work says they are fine?

What's fascinating here is that scenario is the exact reason older patients fall into

You've just described the creatinine trap.

The creatinine trap.

Yes.

As a nurse, you must look at creatinine clearance to assess kidney function in an older adult, not standard serum creatinine levels.

Okay, walk us through the biology of why serum creatinine is essentially lying to us in this population.

It comes down to where serum creatinine originates.

It is a direct metabolic byproduct of lean muscle mass.

Which we just said goes down as we age.

Exactly.

Lean muscle mass naturally wastes away as we age, completely in parallel with the age -related decline in kidney function.

So imagine an 85 -year -old patient who weighs 100 pounds.

She has very little muscle mass, which means she's producing almost no creatinine on a daily basis.

Right.

Her kidneys could be in utter failure, filtering almost nothing out of the blood.

But because her frail muscles are producing barely any creatinine to begin with, the serum level circulating in her blood looks perfectly normal on a standard lab report.

It's an illusion of health.

It is a dangerous illusion.

That's why creatinine clearance, which measures how effectively the kidneys are actually clearing whatever small amount of creatinine is there, is the only reliable index of renal function for older adults taking drugs eliminated by the kidneys.

That is the kind of biological insight that saves lives on the floor.

So we've covered the pharmacokinetics, what the aging body does to the drug.

Now we have to look at pharmacodynamics, what the drug does to the body at the cellular and receptor level.

Well, geriatric research is notoriously limited in this specific area.

We do know that receptor properties physically alter.

Like with beta blockers?

Yes.

Take beta adrenergic blocking agents used heavily for cardiac disorders.

They are simply less effective in older adults, even when plasma concentrations are identical to a younger patient.

Why is that?

The working physiological theory is that there is either a sheer reduction in the number of beta receptors present on the tissue or a reduction in the affinity, the magnetic attraction, if you will, of those receptors for the drug molecule.

So beta blockers do less, but other drug classes do significantly more.

Right.

Drugs like warfarin and particularly central nervous system depressants produce cellular effects that are much more intense in older adults.

Meaning for those specific pathways, receptors might actually increase in number or their affinity becomes heightened.

Exactly.

And when you combine a sluggish processing plant with shifting cellular receptors, you get an absolute avalanche of adverse drug reactions.

The stats here are sobering.

ADRs are seven times more common in older adults than in younger adults.

They account for 16 % of hospital admissions for older individuals and 50 % of all medication -related deaths.

It's huge.

And what makes mitigating this so incredibly difficult for a nurse is that the symptoms of these ADRs in older adults are often maddeningly non -specific.

Like just feeling off.

We're talking about a sudden onset of dizziness, a loss of appetite or cognitive impairment.

A provider or even a family member might casually assume it's just old age or advancing dementia rather than a toxic drug accumulation.

There's also a deeply ingrained social factor, the material points out.

Generational taboos in certain demographics mean older adults might be highly reluctant to reveal alcohol intake or recreational drug use.

Oh, definitely.

If they're hiding a daily cocktail, it completely confounds the nurse's effort to identify the true mechanism of a sudden drug interaction.

It requires immense tact during a patient history because it's rarely just aging causing the ADR.

No, it's a perfect storm of compounding risk factors.

Greater severity of illness, the presence of multiple comorbidities, polypharmacy, which is the simultaneous use of multiple drugs, and the use of medications with a low therapeutic index.

Drugs where the line between a helpful dose and a toxic dose is razor thin.

Digoxin for heart failure is a classic example.

Exactly the kind of drug that requires relentless monitoring.

So understanding these underlying mechanisms is crucial.

But as a nurse on the floor, you need actual clinical armor.

You need standardized tools to intercept these adverse reactions before they happen.

And the medical community has developed highly specific frameworks for this.

Two of the most heavily relied upon are the Beers criteria and the Start Stop PP tools.

The Beers list identifies drugs with a high likelihood of causing adverse effects in older adults, drugs that should generally be avoided unless the benefits overwhelmingly outweigh the risks.

And then there's the S .P .P.

criteria,

the screening tool of older person's potentially inappropriate prescriptions.

It was originally developed for the UK National Health Service, but has seen widespread adoption.

What's unique about SATA PP?

Well, it doesn't just look at the raw biology.

It considers the economic costs and practical burdens of drug therapy.

Furthermore, it's designed to be used alongside start the screening tool to alert doctors to right treatment.

It doesn't just tell you what poison to avoid.

It actively guides providers toward the most appropriate evidence based treatments for that age group.

Exactly.

It creates a much more holistic safety net.

Here's where it gets really interesting.

This is where the rubber meets the road for a nurse reviewing a chart.

There is a list of red flag drugs that might look completely harmless to a lay person, but are essentially toxic to an aging body.

Right.

Let's look at a few major culprits from the beers criteria and discuss the biological mechanisms behind the warning.

First up, NSAIDs like ibuprofen or naproxen.

We take them all the time for headaches.

Why are they a massive red flag for an 80 year old?

The primary danger is a high risk for gastrointestinal bleeding.

But the mechanism you really have to watch is renal function.

NSAIDs work by inhibiting prostaglandins.

And a young person blocking prostaglandins reduces inflammation and pain.

But older adults often rely heavily on those specific prostaglandins to keep the blood vessels in their kidneys dilated and functioning.

So if you block that prostaglandin synthesis with daily ibuprofen, the renal vessels constrict and you can throw an already fragile patient into acute renal failure.

It's a direct devastating chain reaction.

Let's talk about first generation antihistamines like diphenhydramine, commonly known as Benadryl, often used over the counter for sleep.

These are heavily flagged for their severe anticholinergic effects.

They block the neurotransmitter acetylcholine throughout the body.

In an older adult, this blockade leads to profound systemic drying, like severe dry mouth, devastating constipation, urinary retention.

And critically, it crosses the blood brain barrier to cause significant cognitive impairment and delirium.

It just shuts down the parasympathetic nervous system's ability to keep things moving.

What about alpha one blockers like doxazosin commonly prescribed for hypertension?

The mechanism of an alpha one blocker is to cause vasodilation, relaxing the blood vessels to lower pressure.

But in an older body with sluggish autonomic reflexes, this creates a massive risk for orthostatic hypotension.

When the patient stands up, their blood vessels don't constrict fast enough to fight gravity.

Blood pressure plummets.

The brain loses perfusion for a split second and the patient falls.

And in geriatrics, a fall often leads to a hip fracture, which carries a staggering mortality rate.

Exactly.

It's never just about the drug.

It's about the cascade of events and the drug triggers.

Let's look at one more sedative hypnotic, specifically benzodiazepines.

Right.

The central nervous system in older adults is already highly sensitive.

Benzodiazepines cause intense sedation and cognitive impairment.

The mechanism slows motor function and reaction times, which again leads directly to falls,

physical dependence and paradoxical delirium.

So if you are staring down a chart full of these high risk medications,

what are the actionable nursing implications?

How do you actively intervene?

The most vital intervention is conducting a comprehensive, ruthlessly accurate drug history.

And this goes far beyond just reading the electronic health record.

You have to ask the patient how they actually take the medication at home to see if it matches the physician's orders.

Yes, you have to play detective.

Are they taking over the counter sleep aids that contain diphenhydramine on top of a prescribed anticholinergic?

Are they doubling up on Tylenol?

You also have to accommodate for age related deficits during patient education.

Absolutely.

If you are explaining a complex dosing schedule, you must account for decreased vision.

Are your printed instructions actually legible to them?

If there are mild cognitive deficits or hearing loss, you absolutely must include a family member or caregiver in the education process.

It's a brutal reality check.

We spend all this energy mapping out the perfect pharmacokinetic interventions and screening for beers list contraindications.

But eventually you hit the ultimate clinical wall, which is you can prescribe the safest, most perfectly tailored drug regimen in the world, but it is completely useless if the patient refuses to take it.

Oh yeah.

Non -adherence is the silent saboteur of geriatric pharmacology.

The clinical data indicates that between 26 % and 59 % of older adults fail to take their medicines as prescribed.

And the vast majority of the time, this results in underdosing leading straight to therapeutic failure.

Now, if I'm a young nursing student reading this, my immediate assumption is that this is mostly unintentional.

It's forgetfulness.

It's bad eyesight making the labels blurry,

or it's those impossible to open childproof pill bottles that require severe grip strength.

This raises an important question though.

While those mechanical and cognitive barriers absolutely exist and must be addressed, they obscure a much more challenging reality.

The data reveals that in approximately 75 % of cases, non -adherence among older adults is completely intentional.

75 % intentional.

That is wild.

They are making a conscious active choice to disregard the medical directive.

What is driving that mechanism of refusal?

It largely comes down to patient autonomy and their perception of the treatment.

The principal reason is a deeply held personal conviction that the drug simply isn't needed in the dosage prescribed.

They don't feel a difference.

So they stop.

Or the cure feels worse than the disease.

Precisely.

Unpleasant side effects that ruin their day -to -day life are a massive driver.

If a blood pressure medication makes them too dizzy to safely walk to their mailbox, they will stop taking it.

And we cannot ignore the sheer financial toxicity of the US healthcare system.

The inability to pay for expensive refills forces patients to ration or abandon their medications entirely.

Without a doubt.

So when we look at the clinical data on how to actually solve non -adherence, the interventions have to completely depend on the patient's underlying motivation.

Right.

If the barrier is unintentional, sure.

Suggest a daily pill counter.

Have the pharmacy use large print labels and easy to open non -child proof containers and list a visiting nurse to help organize the week.

But those mechanical fixes are entirely useless if the non -adherence is intentional.

You can put the easiest to open lid in the world on a bottle, but if the patient can't afford the copay or if the drug gives them agonizing stomach cramps, that bottle is going to sit unopened on the nightstand.

For intentional non -adherence, the solution requires intense empathetic nursing communication.

You have to verify they can actually afford the treatment.

You have to advocate to simplify the regimen to as few doses as possible.

And critically, you have to verify that the drug side effects aren't destroying their quality of life,

which logically leads us to the final phase of pharmacological care.

Because biology eventually dictates a shift.

There comes a point where chronic disease management is no longer the priority.

Right.

When a patient enters end of life care, all those rigid rules and screening tools we just talked about get thrown completely out the window.

The clinical goalposts shift entirely from extending life to the strict uncompromising provision of comfort.

It requires a massive mental pivot for a nurse.

Drugs that were once deemed absolutely vital for long -term health -like statins for cholesterol or vitamins are immediately discontinued because preventing a heart attack 10 years down the line is no longer relevant.

Conversely, drugs that were once strictly avoided because the beers list like heavy sedatives or potent opioids suddenly become central to providing compassionate care.

Let's look at the pharmacology of managing specific end of life symptoms, starting with constipation.

In a palliative setting, constipation is very frequently opioid induced due to heavy pain management.

Therefore an order for scheduled opioids should almost always be accompanied by an order for a bowel regimen.

First line choices are osmotic laxatives, right?

Yes.

If it's refractory, meaning it's not responding, a specialized targeted drug like methylnoltrexone can be used.

Crucially,

standard stimulant laxatives should be avoided if the patient is prone to abdominal cramping, as that just introduces new pain.

What about managing terminal delirium?

Delirium should be managed with anti -psychotics like haloperidol or olanzapine.

You remember those benzodiazepines we warned heavily about earlier?

The fall risk.

Right.

At the end of life, they can sometimes cause paradoxical agitation making the delirium worse, though they might still be used short -term to supplement anti -psychotics for severe acute episodes.

Dyspnea or severe shortness of breath.

This is incredibly common and frightening for the patient.

It is.

Interestingly, opioids are actually a first line pharmacological choice for dyspnea.

Oh, opioids.

Yeah.

The mechanism here is that opioids blunt the medullary response to hypoxia and hypercapnia, effectively reducing the sensation of breathlessness and the severe anxiety that accompanies it.

This is used alongside oxygen and glucocorticoids.

Let's talk about the cornerstone of end of life care, pain management.

The most vital paradigm shift for a nurse here is abandoning any fear of addiction.

Addiction concerns are entirely irrelevant at this stage.

Pain medications must be scheduled around the clock rather than PRN or as needed to prevent pain from ever breaking through.

Because the liver and kidneys are actively failing, opioids can accumulate.

Fentanyl is often the drug of choice for severe pain in patients with concurrent renal and hepatic dysfunction because of how it metabolizes.

Finally, there's a symptom commonly referred to as the death rattle, the pooling of respiratory secretions in the airway as the patient loses their ability to cough or swallow.

It sounds incredibly distressing.

What is the pharmacological intervention here?

Well, if drug therapy is desired,

anticholinergics are highly effective.

We talked earlier about how they cause extreme drying.

Here, we use that mechanism to our advantage to dry up those airway secretions.

Like glycopyrrolate.

Yes, glycopyrrolate is often the anticholinergic of choice because it doesn't cross the blood brain barrier as easily, meaning fewer central nervous system adverse effects.

But there is a vital patient teaching point here for nurses interacting with the family, right?

Absolutely.

Clinical consensus generally agrees that this rattle does not physically hurt or distress the unconscious patient.

However, the sound is deeply traumatizing to the family members standing vigil.

So administering an anticholinergic in this specific instance is often more about bringing immense emotional comfort to the grieving family in the room than it is about treating the patient's pain.

Exactly.

So what does this all mean?

We've traced the entire journey.

We explored the mechanics of how a changing body composition and sluggish blood flow altered drug absorption and distribution.

We unpacked the hidden danger of the creatinine trap where normal lab results mask failing kidneys.

We examined how shifting cellular receptors ignite an avalanche of adverse reactions and how tools like the beers criteria give you the power to intercept them.

We confronted the reality that patients often intentionally reject their meds to preserve their autonomy.

And we saw how nursing priorities completely invert at the end of life to focus entirely on human comfort.

If we pull back and look at the broader implications of all this pharmacology, I won't leave you with a provocative thought based on the clinical data.

Let's hear it.

If aging fundamentally alters how a body processes chemicals and if drug toxicity often masquerades as dizziness, fatigue, or cognitive decline,

how much of what we casually accept as normal aging or standard cognitive decline in our older patients is actually just an unrecognized, completely preventable adverse drug reaction.

Wow.

It changes how you look at every single symptom.

It's not a clean equation.

It's murky water.

And as a nurse, you are the one armed with the pharmacology to see clearly through it.

Thank you for studying with us today.

And a warm thank you from the last minute lecture team.

Keep asking the right questions and good luck on those exams.